Compare QNCX & MRBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | QNCX | MRBK |
|---|---|---|
| Founded | 2012 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 167.0M | 198.4M |
| IPO Year | 2019 | 2017 |
| Metric | QNCX | MRBK |
|---|---|---|
| Price | $2.81 | $17.54 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 3 |
| Target Price | $7.67 | ★ $18.00 |
| AVG Volume (30 Days) | ★ 698.3K | 102.1K |
| Earning Date | 11-12-2025 | 01-23-2026 |
| Dividend Yield | N/A | ★ 2.85% |
| EPS Growth | N/A | ★ 75.95 |
| EPS | N/A | ★ 1.77 |
| Revenue | N/A | ★ $109,758,000.00 |
| Revenue This Year | N/A | $26.84 |
| Revenue Next Year | N/A | $8.90 |
| P/E Ratio | ★ N/A | $9.92 |
| Revenue Growth | N/A | ★ 18.84 |
| 52 Week Low | $0.72 | $11.16 |
| 52 Week High | $4.55 | $18.33 |
| Indicator | QNCX | MRBK |
|---|---|---|
| Relative Strength Index (RSI) | 38.83 | 61.74 |
| Support Level | $3.18 | $17.09 |
| Resistance Level | $3.38 | $17.93 |
| Average True Range (ATR) | 0.27 | 0.42 |
| MACD | -0.17 | -0.10 |
| Stochastic Oscillator | 6.51 | 35.89 |
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
Meridian Corp is a bank holding company. Through its banking subsidiary, it operates as a full-service, state-chartered commercial bank providing personal, business lending, and deposit services. It operates in three reportable segments including Bank, Wealth, and Mortgage. The company generates maximum revenue from the Bank segment which consists of commercial and retail banking. It generates interest income from its lending (including leasing) and investing activities and is dependent on the gathering of lower-cost deposits from its branch network or borrowed funds from other sources for funding its loans.